Drugs / RV5
last change May 2016 re-read 3 minutes ago

RV5

Vaccine

Developed for
diarrheal disease · gastroenteritis
Investigated by
Dennis Clements · Merck Sharp & Dohme LLC

Trials 1

20142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT01960725 Feb 2014 → Dec 2015 diarrheal disease, gastroenteritis Dennis Clements Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as RV5 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01960725 ↗
Known as Pentavalent Rotavirus Vaccine “RV5 (Pentavalent Rotavirus Vaccine)” NCT01960725 ↗
Modality Vaccine “pentavalent rotavirus vaccine (RV5)” NCT01960725 ↗